Inovio Pharmaceuticals
INO
INO
84 hedge funds and large institutions have $137M invested in Inovio Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.33% more ownership
Funds ownership: 1.6% → 1.93% (+0.33%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
39% less call options, than puts
Call options by funds: $4.24M | Put options by funds: $6.92M
Holders
84
Holding in Top 10
1
Calls
$4.24M
Puts
$6.92M
Top Buyers
1 | +$7.36M | |
2 | +$4.87M | |
3 | +$3.5M | |
4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$2.46M |
5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2.24M |
Top Sellers
1 | -$3.96M | |
2 | -$1.51M | |
3 | -$1.07M | |
4 |
Jane Street
New York
|
-$843K |
5 |
Millennium Management
New York
|
-$665K |